MECHANISM OF HIPPOCAMPAL CD95/CD95L AND BDNF/TRKB PATHWAY IN THE DEVELOPMENT OF TRIGEMINAL NEURALGIA IN RATS

被引:1
|
作者
Deng, Ruyun [1 ]
机构
[1] Daqing Oilfield Gen Hosp, Dept Anesthesia Surg, Daqing 163000, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 03期
关键词
Hippocampus; CD95; CD95L pathway; BDNF; TrkB pathway; trigeminal neuralgia; mechanism;
D O I
10.19193/0393-6384_2022_3_328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aims to explore the mechanism of hippocampal apoptotic factor CD95 and its ligand (CD95L) pathway, as well as brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase B (TrkB) pathway, in the development of trigeminal neuralgia in rats. Methods: Forty healthy adult male SD rats were randomly divided into control and model groups. The model group was used to establish the trigeminal neuralgia model, while the control group was exposed to the infraorbital nerve without ligation. The mechanical pain domain was measured before the operation, 5 days after the operation, 15 days after the operation, and 30 days after the operation. The learning and memory function of rats was evaluated by a water maze test 30 days after modeling. The relative expression levels of interleukin-113 (IL-1 13), Caspase-3, BDNF, TrkB, CD95, and CD95L were detected by Western blot. Results: There was no significant difference in mechanical pain area between the two groups before operation (P 0.05). The mechanical pain area of the model group was significantly lower than that of the control group at 5, 15, and 30 days after the operation (P<0.05). The escape latency level of the model group was significantly higher than that of the control group (P<0.05). The times of crossing the platform and the percentage of time in the target quadrant in the model group were significantly lower than those in the control group (P<0.05). IL-1 in model group 13 The protein levels of Caspase-3 and Caspase-3 in the treatment group were significantly higher than those in the control group (P<0.05). The protein levels of BDNF and TrkB in the model group were significantly lower than those in the control group (P<0.05). The protein levels of CD95 and CD95L in the model group were significantly higher than those in the control group (P<0.05). Conclusion: Hippocampal CD95/CD95L and BDNF/TrkB pathways mediate the trigeminal neuralgia occurrence and development in rats by regulating neuroinflammation and neuronal apoptosis and even leading to cognitive impairment in rats.
引用
收藏
页码:2147 / 2151
页数:5
相关论文
共 50 条
  • [1] Trigeminal neuralgia causes neurodegeneration in rats associated with upregulation of the CD95/CD95L pathway
    Wang, Lu
    Long, Menghong
    Wang, Maohua
    Peng, Shuangchun
    Chen, Guangxiang
    Zhou, Jun
    Ou, Cehua
    MOLECULAR PAIN, 2020, 16
  • [2] The CD95/CD95L signaling pathway: A role in carcinogenesis
    Fouque, Arnelie
    Debure, Laure
    Legembre, Patrick
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (01): : 130 - 141
  • [3] The dual role of the CD95 and CD95L signaling pathway in glioblastoma
    Zhang, Yanrui
    Jin, Taian
    Dou, Zhangqi
    Wei, Boxing
    Zhang, Buyi
    Sun, Chongran
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] CD95/CD95L interactions and their role in autoimmunity
    Ricci-Vitiani, L
    Conticello, C
    Zeuner, A
    De Maria, R
    APOPTOSIS, 2000, 5 (05) : 419 - 424
  • [5] CD95/CD95L interactions and their role in autoimmunity
    L. Ricci-Vitiani
    C. Conticello
    A. Zeuner
    R. De Maria
    Apoptosis, 2000, 5 : 419 - 424
  • [6] Apoptosis in neuroblastomas induced by interferon-γ involves the CD95/CD95L pathway
    Annicchiarico-Petruzzelli, M
    Bernassola, F
    Lovat, PE
    Redfern, CPF
    Pearson, ADJ
    Melino, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01): : 115 - 117
  • [7] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [8] CD95 and CD95L promote and protect cancer stem cells
    Ceppi, Paolo
    Hadji, Abbas
    Kohlhapp, Frederick J.
    Pattanayak, Abhinandan
    Hau, Annika
    Liu, Xia
    Liu, Huiping
    Murmann, Andrea E.
    Peter, Marcus E.
    NATURE COMMUNICATIONS, 2014, 5
  • [9] CD95 and CD95L in gastrointestinal cancer patients peripheral blood
    Jaunalksne, Into
    Donina, Simona
    Engele, Ludmila
    Romanova, Tatjana
    CLINICAL IMMUNOLOGY, 2008, 127 : S146 - S146
  • [10] CD95 and CD95L promote and protect cancer stem cells
    Paolo Ceppi
    Abbas Hadji
    Frederick J. Kohlhapp
    Abhinandan Pattanayak
    Annika Hau
    Xia Liu
    Huiping Liu
    Andrea E. Murmann
    Marcus E. Peter
    Nature Communications, 5